Adult mice expressing a Braf Q241R mutation on an ICR/CD-1 background exhibit a cardio-facio-cutaneous syndrome phenotype.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Human Molecular Genetics

• Publication date

  2015-12-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/hmg/ddv435PMID 26472072
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New BRAF knockin mice provide a pathogenetic mechanism of developmental defects and a therapeutic approach in cardio-facio-cutaneous syndrome.

  2014cited by this paper
• The perinatal presentation of cardiofaciocutaneous syndrome

  2014cited by this paper
• Cardio-Facio-Cutaneous Syndrome: Clinical Features, Diagnosis, and Management Guidelines

  2014influential reference
• Teratogenicity of asbestos in mice.

  2014cited by this paper
• The RASopathies.

  2013cited by this paper
• Hesr2 Knockout Mice Develop Aortic Valve Disease With Advancing Age

  2013cited by this paper
• The intermediate-activity (L597V)BRAF mutant acts as an epistatic modifier of oncogenic RAS by enhancing signaling through the RAF/MEK/ERK pathway.

  2012influential reference
• Developmental toxicity study of lersivirine in mice.

  2012cited by this paper
• Prevalence and clinical features of Costello syndrome and cardio‐facio‐cutaneous syndrome in Japan: Findings from a nationwide epidemiological survey

  2012cited by this paper
• Continual low-level MEK inhibition ameliorates cardio-facio-cutaneous phenotypes in zebrafish

  2012cited by this paper
• Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation.

  2011cited by this paper
• Bone resorption in syndromes of the Ras/MAPK pathway

  2011cited by this paper
• Cardio‐facio‐cutaneous syndrome: Does genotype predict phenotype?

  2011influential reference
• Constitutive activation of B-Raf in the mouse germ line provides a model for human cardio-facio-cutaneous syndrome

  2011influential reference
• P301S Mutant Human Tau Transgenic Mice Manifest Early Symptoms of Human Tauopathies with Dementia and Altered Sensorimotor Gating

  2011cited by this paper
• Effects of germline mutations in the Ras/MAPK signaling pathway on adaptive behavior: Cardiofaciocutaneous syndrome and Noonan syndrome

  2010cited by this paper
• Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: Molecular diversity and associated phenotypic spectrum

  2009cited by this paper
• Noonan syndrome cardiac defects are caused by PTPN11 acting in endocardium to enhance endocardial-mesenchymal transformation

  2009cited by this paper
• Kinase-activating and kinase-impaired cardio-facio-cutaneous syndrome alleles have activity during zebrafish development and are sensitive to small molecule inhibitors

  2009cited by this paper
• The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation.

  2009cited by this paper
• The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders

  2008cited by this paper
• The cardiofaciocutaneous syndrome: prenatal findings in two patients

  2008cited by this paper
• Effect of low dose of vinclozolin on reproductive tract development and sperm parameters in CD1 outbred mice.

  2008cited by this paper
• Molecular and clinical characterization of cardio‐facio‐cutaneous (CFC) syndrome: Overlapping clinical manifestations with Costello syndrome

  2007cited by this paper
• Further delineation of cardio-facio-cutaneous syndrome: clinical features of 38 individuals with proven mutations

  2007cited by this paper
• Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome

  2006cited by this paper
• Germline Mutations in Genes Within the MAPK Pathway Cause Cardio-facio-cutaneous Syndrome

  2006cited by this paper
• RAS oncogenes: the first 30 years

  2003cited by this paper
• Mutations of the BRAF gene in human cancer

  2002cited by this paper
• Akt/Protein Kinase B Promotes Organ Growth in Transgenic Mice

  2002cited by this paper
• Altered performance characteristics in cognitive tasks: comparison of the albino ICR and CD1 mouse strains.

  2002cited by this paper
• A Ca2+-Dependent Transgenic Model of Cardiac Hypertrophy: A Role for Protein Kinase C&agr;

  2001cited by this paper
• A Ca(2+)-dependent transgenic model of cardiac hypertrophy: A role for protein kinase Calpha.

  2001cited by this paper
• Hyperactivity and Intact Hippocampus-Dependent Learning in Mice Lacking the M1 Muscarinic Acetylcholine Receptor

  2001cited by this paper
• The MEK1–ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice

  2000cited by this paper
• Distinct molecular phenotypes in murine cardiac muscle development, growth, and hypertrophy.

  1998cited by this paper
• Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium.

  1997cited by this paper
• Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload.

  1995cited by this paper
• New multiple congenital anomalies/mental retardation syndrome with cardio-facio-cutaneous involvement--the CFC syndrome.

  1986cited by this paper

• Genetic activation of ERK2 recapitulates core neurodevelopmental features of Rasopathy syndromes in mice

  2025cites this paper
• Aberrant ERK signaling in astrocytes impairs learning and memory in RASopathy-associated BRAF mutant mouse models

  2025cites this paper
• Q241R mutation of Braf causes neurological abnormalities in a mouse model of cardio-facio-cutaneous syndrome, independent of developmental malformations.

  2025cites this paper
• The RASopathies: from pathogenetics to therapeutics

  2022cites this paper
• Hop Mice Display Synchronous Hindlimb Locomotion and a Ventrally Fused Lumbar Spinal Cord Caused by a Point Mutation in Ttc26

  2022cites this paper
• RASopathies: the Musculoskeletal Consequences and their Etiology and Pathogenesis.

  2021cites this paper
• Translating the Role of mTOR- and RAS-Associated Signalopathies in Autism Spectrum Disorder: Models, Mechanisms and Treatment

  2021cites this paper
• BRAF mutations disrupt the hypothalamo-pituitary axis leading to hypopituitarism in mouse and humans 1

  2021cites this paper
• Activating mutations in BRAF disrupt the hypothalamo-pituitary axis leading to hypopituitarism in mice and humans

  2021cites this paper
• A point mutation in Ttc26 causes lumbar spinal cord fusion and synchronous hind-limb locomotion in hop mice

  2020cites this paper
• The impact of RASopathy-associated mutations on CNS development in mice and humans

  2019cites this paper
• New Noonan syndrome model mice with RIT1 mutation exhibit cardiac hypertrophy and susceptibility to β-adrenergic stimulation-induced cardiac fibrosis

  2019cites this paper
• C‐type natriuretic peptide improves growth retardation in a mouse model of cardio‐facio‐cutaneous syndrome

  2018cites this paper
• Mek1Y130C mice recapitulate aspects of human cardio-facio-cutaneous syndrome

  2018cites this paper
• ERK/MAPK signaling and autism spectrum disorders.

  2018cites this paper
• Activated Braf induces esophageal dilation and gastric epithelial hyperplasia in mice

  2017cites this paper
• Mice with an Oncogenic HRAS Mutation are Resistant to High-Fat Diet-Induced Obesity and Exhibit Impaired Hepatic Energy Homeostasis

  2017cites this paper
• Cognitive Dysfunctions in Intellectual Disabilities: The Contributions of the Ras-MAPK and PI3K-AKT-mTOR Pathways.

  2017cites this paper
• Impaired Osteogenesis of Disease-Specific Induced Pluripotent Stem Cells Derived from a CFC Syndrome Patient

  2017cites this paper
• RAS and downstream RAF-MEK and PI3K-AKT signaling in neuronal development, function and dysfunction

  2016cites this paper
• Cell type-specific roles of RAS-MAPK signaling in learning and memory: Implications in neurodevelopmental disorders.

  2016cites this paper